Susquehanna International Group
LUCD icon

Susquehanna International Group’s Lucid Diagnostics LUCD Stock Holding History

Susquehanna International Group’s Portfolio LUCD Stock Details LUCD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$119K Buy
+103,174
New +$131K ﹤0.01% 12220
2025
Q3 		– Sell
-84,442
Closed -$97.1K – 13253
2025
Q2 		$97.1K Sell
84,442
-106,013
-56% -$137K ﹤0.01% 11814
2025
Q1 		$284K Buy
+190,455
New +$229K ﹤0.01% 10175
2022
Q1 		– Sell
-13,255
Closed -$71K – 13571
2021
Q4 		$71K Buy
+13,255
New +$108K ﹤0.01% 12365

Other funds holding LUCD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
MCM
Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return

Susquehanna International Group's LUCD Position: Q1 2026 in Review

Susquehanna International Group opened a new position in Lucid Diagnostics (LUCD) in Q1 2026: 103,174 shares worth $119K. The stake represents ﹤0.01% of the portfolio and ranks #12220 among its holdings. This is a return to the name: Susquehanna International Group previously reported a position in LUCD as recently as Q2 2025.

Susquehanna International Group first reported a position in LUCD in Q4 2021 and has held it in 4 quarters since. The position peaked at $284K in Q1 2025. 103 funds tracked by Wall St. Rank hold LUCD as of Q1 2026.

  • Susquehanna International Group held 103,174 shares of Lucid Diagnostics worth $119K as of Q1 2026.
  • Lucid Diagnostics was a new Susquehanna International Group position in Q1 2026.
  • Lucid Diagnostics made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #12220 holding.
  • Susquehanna International Group first reported a position in Lucid Diagnostics in Q4 2021 and has held it in 4 quarters since.
  • Susquehanna International Group's Lucid Diagnostics position peaked at $284K in Q1 2025.
  • 103 funds tracked by Wall St. Rank held Lucid Diagnostics as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.